Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects

Nutr Metab Cardiovasc Dis. 1999 Feb;9(1):19-24.

Abstract

Background and aim: The heterogeneous population of HDL particles can be separated into six classes which may provide a more sensitive index of cardiovascular risk than HDL cholesterol. The aim of this study was therefore to evaluate HDL distribution in NIDDM.

Methods and results: Twenty-five individuals were treated with diet and sulfonylurea and 14 with insulin; both groups had similar plasma lipid profiles and BMI, but the insulin-treated subjects were older and their diabetes was of longer duration. The major findings were a greater proportion of apoA1 in alpha 1-HDL in the insulin-treated group (24.3 +/- 5.2% vs 20.8 +/- 4.0%), which is a desirable profile, and a greater proportion of pre-beta 1-HDL, which are the initial acceptors of cellular cholesterol.

Conclusions: Our results suggest a beneficial influence of insulin treatment on reverse cholesterol transport. Moreover, glycemic control (HbA1c) also related to alpha 3-HDL significantly (r = 0.51; p < 0.01), indicating an association between poorer glycemic control and an adverse HDL profile.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Analysis of Variance
  • Blood Glucose / metabolism
  • Cholesterol, HDL / drug effects*
  • Cholesterol, HDL / metabolism*
  • Diabetes Mellitus, Type 2 / diet therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diet Therapy / methods
  • Electrophoresis
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Immunoblotting
  • Insulin / administration & dosage*
  • Male
  • Middle Aged
  • Sensitivity and Specificity

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Hypoglycemic Agents
  • Insulin